ss Stent control group. They reported a significant reduction in small... ...TAXUS Liberte Approval in Japan. In January 2009 we announced that BSC... ...Financial and Strategic Alternatives Process. Over the last two years...

ss Stent control group. They reported a significant reduction in small vessel in-stent restenosis (re-narrowing of a blood vessel) and major adverse coronary events in patients treated with the TAXUS Liberte Atom Stent, and a significantly reduced rate of myocardial infarction (heart attack) in patients with long lesions treated with the TAXUS Liberte Long Stent.

TAXUS Liberte Approval in Japan. In January 2009 we announced that BSC had received approval from the Japanese Ministry of Health, Labor and Welfare to market the TAXUS Liberte in Japan. BSC plans to launch the product in Japan once reimbursement approval is granted. TAXUS Liberte is the only second-generation drug-eluting stent approved for use in Japan. The TAXUS Liberte stent will replace the TAXUS Express2 stent, marketed in Japan since May 2007.

Financial and Strategic Alternatives Process. Over the last two years, revenue in our Pharmaceutical Technologies segment has declined significantly, primarily due to lower royalties derived from sales by BSC of TAXUS coronary stent systems. This decline in royalty revenue has negatively and materially impacted our liquidity and results of operations. During 2008, our management and Board of Directors decided to explore and pursue various restructuring and cost reduction actions as well as various financial and strategic transactions that could potentially reduce or eliminate our existing debt obligations and improve our working capital position. On November 21, 2008, we announced that we had engaged The Blackstone Group to assist us in evaluating various alternatives for our business and capital structure, including, but not limited to, securing interim senior secured financing for working capital and liquidity purposes evaluating various restructuring alternatives to pursue with the holders of our Senior Floating Rate Notes due 2013 and our 7.75% Senior Subordinated Notes due 2014, and assisting us in evaluating proposals or '/>"/>

(Date:7/29/2015)... -- Indivior PLC (LON: INDV) today announced that the New ... and received Priority Review by the U.S. Food and ... This naloxone nasal spray comes as a pre-filled device ... the nasal mucosa. 1 The device has been ... better equipped to help an opioid overdose victim. ...

(Date:7/29/2015)... - RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSX.V: RP), ... announce that the final design specifications of its ... for industrial and regulatory testing will now be ... mark clearance to market the injector in ... (Photo: http://photos.prnewswire.com/prnh/20150729/248373 ) The RCI-02 ...

(Date:7/29/2015)... ... 2015 , ... Finding gooey or crusty material in the corner of your ... considerable number of terms in popular use to describe it, ophthalmologists call it “gound” ... mucus, blood cells, skin cells and dust, but until now there has been virtually ...

... PharmAthene, Inc. (NYSE Amex: PIP ), ... chemical threats, today reported financial and operational results for ... 2010. For the third quarter of 2010, ... million in the same period of 2009. For the ...

... Oligomerix, Inc. today announced the receipt of a ... for $1.6M from the National Institute on Aging, National ... small molecules and antibodies targeting tau protein oligomers in ... Compound libraries will be screened at the Michigan High ...

... a new report on regional marine research and information ... fisheries, ocean health, coastal hazards and climate change - ... region,s annual $32-billion ocean-related economy, according to a new ... The report, West Coast Regional Marine Research and ...

... This release is available in German . ... the tiny surface of a biochip. They permit the rapid ... These biochips are already in widespread use for DNA testing. ... produce. This is because the proteins have a defined three-dimensional ...

... Researchers from the University of California, Davis have developed ... fragile X mental retardation 1 (FMR1) protein (FMRP), which is ... Iwahashi et al, "A quantitative ELISA assay for the fragile ... issue of the Journal of Molecular Diagnostics . ...

... contains 4 deuterium atoms at the 9, 10, ... use as an internal standard for the quantification ... is produced by the lipoxygenation of linoleic acid ... detected in atherosclerotic plaques, as an esterified component ...